Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, aXichem AB's Enterprise Value is €15.77 Mil.
aXichem AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €-1.03 Mil. Therefore, aXichem AB's EV-to-FCF for today is -15.29.
The historical rank and industry rank for aXichem AB's EV-to-FCF or its related term are showing as below:
FRA:A6X'
s EV-to-FCF Range Over the Past 10 Years
Min: -121.51 Med: -14.16 Max: -2
Current: -15.54
During the past 13 years, the highest EV-to-FCF of aXichem AB was -2.00. The lowest was -121.51. And the median was -14.16.
FRA:A6X's EV-to-FCF is ranked worse than 100% of 926
companies
in the Chemicals industry
Industry Median: 21.54
vs FRA:A6X: -15.54
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
aXichem AB's share price for today is €0.211.
aXichem AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.023.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
aXichem AB EV-to-FCF Related Terms
aXichem AB EV-to-FCF Historical Data
* Premium members only.
The historical data trend for aXichem AB's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, aXichem AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
aXichem AB EV-to-FCF vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, aXichem AB's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where aXichem AB's EV-to-FCF falls into.
aXichem AB's current Enterprise Value is €15.77 Mil.
aXichem AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.03 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
aXichem AB (FRA:A6X) has a EV-to-FCF of -15.29 as of Jul. 18, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on aXichem AB and its competitors. According to the industry distribution chart, aXichem AB ranks #999999 out of 926 companies in the Chemicals industry.
Is aXichem AB's EV-to-FCF too high?
aXichem AB's current EV-to-FCF is -15.29. Based on the distribution chart, aXichem AB ranks #999999 out of 926 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, aXichem AB has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does aXichem AB's EV-to-FCF compare to LIN and SHW?
According to the Chemicals industry distribution chart, aXichem AB ranks #999999 out of 926 companies for EV-to-FCF. This places aXichem AB in the lower half of its industry. The industry median EV-to-FCF is 21.54. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Chemicals company?
The median EV-to-FCF among Chemicals companies is 21.54, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on aXichem AB and its competitors. For the Chemicals industry, the median EV-to-FCF is 21.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. aXichem AB's current EV-to-FCF is -15.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aXichem AB stock overvalued right now?
aXichem AB (FRA:A6X) has a current EV-to-FCF of -15.29. The stock's GF Value™ is €0.30, compared to a current price of €0.21 — trading 29.7% below its estimated fair value. The current EV-to-FCF is -15.29. aXichem AB's overall GF Score™ is 65/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For aXichem AB (FRA:A6X), the current EV-to-FCF is -15.29 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is aXichem AB (FRA:A6X) Overvalued in 2026?
Based on GuruFocus' analysis, aXichem AB stock appears to be undervalued.
The current stock price of €0.21 is trading 29.7% below its estimated GF Value™ of €0.30.
Key valuation signals for FRA:A6X:
EV-to-FCF: -15.29
GF Value™: €0.30 vs. price of €0.21 (29.7% below fair value)
No single metric tells the full story. See the FRA:A6X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
aXichem AB develops, patents, markets and sells natural analogue industrial chemicals, which are synthetically produced substances with similar and comparable properties to natural substances. The Company's business concept is to develop, patent, market and sell natural analogue industrial chemicals. Its commercial focus is on the proprietary patented product phenylcapsaicin, the Company's first product, which is marketed under the registered trademarks aXiphen as an additive in animal feed and aXivite as an ingredient in food supplements and as a bioenhancer. The Company's product portfolio comprises Phenylcapsaicin, aXiphen, aXiphen bio, and aXivite. The Company's focus is on establishing aXiphen as an additive in poultry feed and pig feed.
65GF Score
Get the complete analysis for FRA:A6X
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:A6X has been successfully added to your 
